Litigation Details for Boehringer Ingelheim Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
✉ Email this page to a colleague
Boehringer Ingelheim Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-08-25 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2016-07-27 |
| Cause | 35:271 Patent Infringement | Assigned To | John Preston Bailey |
| Jury Demand | None | Referred To | |
| Patents | 8,673,927; 8,846,695; 8,853,156 | ||
| Link to Docket | External link to docket | ||
Details for Boehringer Ingelheim Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-08-25 | 1 | and legally issued United States Patent No. 8,673,927 (“the ‘927 patent”) entitled “Uses of DPP-IV Inhibitors…prior to the expiration of United States Patent Nos. 8,673,927, 8,846,695, and 8,853,156. U.S. DlSTR!…assertion of counterclaims BACKGROUND U.S. Patent No. 8,673,927 29. On March 18, 2014, the PTO duly and…Exhibit US Patent dated 3/18/2014, # 2 Exhibit US Patent dated 9/30/2014, # 3 Exhibit US Patent dated 10…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
